98%
921
2 minutes
20
Purpose: After successful endovascular treatment of acute ischemic stroke, there remains considerable controversy surrounding the efficacy of intensified blood pressure control therapy. Presently, numerous randomized controlled trials have yielded diverse findings. Thus, our objective is to consolidate all current randomized controlled trial data to evaluate whether intensified systolic blood pressure targets, in comparison to standard targets, offer superior safety and efficacy.
Methods: By searching the EMBASE, PubMed, and Cochrane Library databases, we identified randomized controlled trials comparing standard blood pressure control to intensified blood pressure control in patients with acute ischemic stroke undergoing endovascular thrombectomy (EVT). Efficacy outcomes included favorable clinical outcomes (defined as a modified Rankin Scale (mRS) score of 0-2 at 90 days), excellence clinical outcomes (defined as an mRS score of 0-1 at 90 days), and 90-day mortality. Safety outcomes included symptomatic intracranial hemorrhage (sICH). The relationship between standard and intensified blood pressure control post-EVT and the prognosis of patients with acute ischemic stroke undergoing endovascular thrombectomy was expressed using risk ratios (RR) and their corresponding 95% confidence intervals (95% CI).
Results: The analysis encompassed four studies involving a total of 753 patients. After sensitivity analysis and exclusion of literature with significant heterogeneity, it was revealed that compared to intensified blood pressure control, standard blood pressure control was associated with excellent clinical outcomes RR of 0.81 (95% confidence interval [CI]: 0.73-0.90; p < 0.05; I = 25%). However, no significant correlation was found for favorable clinical outcomes, 90-day mortality, and safety outcomes including symptomatic intracranial hemorrhage.
Conclusions: After careful analysis, our conclusion is that intensified blood pressure control, compared to standard blood pressure control following endovascular treatment in acute stroke patients, does not yield better clinical outcomes and may even lead to inferior ones. Moreover, there is no significant disparity in terms of safety between the two approaches.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11807842 | PMC |
http://dx.doi.org/10.1002/brb3.70211 | DOI Listing |
High Blood Press Cardiovasc Prev
September 2025
Department of Cardiology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Blood pressure variability (BPV), independent of mean BP, is an emerging predictor of cardiovascular risk and hypertension-mediated organ damage. However, its clinical utility remains limited due to the lack of clear guideline recommendations, leading to variability in physician practices. Using the modified Delphi method, this is the first Egyptian consensus to provide expert recommendations for integrating BPV in Egypt's resource-limited settings.
View Article and Find Full Text PDFMinerva Anestesiol
September 2025
Department of Cardiac, Thoracic and Vascular Surgery, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Background: Postoperative cognitive dysfunction (POCD) occurs in 20% to 80% of patients following cardiac surgical interventions. The incidence of delirium is from 20% to 50%. Impaired cerebral autoregulation (CA) during cardiopulmonary bypass (CPB) contributes to these issues.
View Article and Find Full Text PDFNed Tijdschr Geneeskd
September 2025
UMC Utrecht, afd. huisartsgeneeskunde, Julius Centrum voor Gezondheidswetenschappen en Eerstelijns Geneeskunde, Utrecht.
Objective: To investigate sex differences in the pharmacological treatment of hypertension in primary care.
Design: Cross-sectional study among 14,384 patients with hypertension from the Julius General Practitioners' Network, without cardiovascular disease or diabetes, treated with antihypertensive medications.
Methods: We compared men and women in the number and type of prescribed antihypertensives and their blood pressure.
J Clin Hypertens (Greenwich)
September 2025
Department of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
This study aims to fill this gap by leveraging Global Burden of Disease 2021 (GBD 2021) data to conduct a comprehensive assessment of the disease burden attributable to high systolic blood pressure (SBP) in young adults. Data from the Global Health Data Exchange were utilized to estimate the disease burden attributable to high SBP in young adults, stratified by overall disease, sex, socio-demographic index (SDI) level, GBD region, nation, and specific disease. In 2021, the overall disease attributable to high SBP in young adults was substantial, with approximately 24,626,362 disability-adjusted life years (DALYs) and 477,992 deaths, and the DALYs and mortality rates were 623.
View Article and Find Full Text PDFPediatr Crit Care Med
September 2025
Waisman Brain Imaging Laboratory, University of Wisconsin, Madison, WI.
Objectives: Elevated intracranial pressure (ICP) is a complication of severe traumatic brain injury (TBI) that carries a risk of secondary brain injury. This study investigated the association between ICP burden and brain injury patterns on MRI in children with severe TBI.
Design, Setting, And Patients: Secondary analysis of the Approaches and Decisions in Acute Pediatric TBI (ADAPT) study, which included children with severe TBI (Glasgow Coma Scale score < 9) who received a clinical MRI within 30 days of injury.